Patients with hepatitis C constitute the highest proportion of candidates f
or liver transplantation. The lack of small animal models for the disease h
as been a major stumbling block in understanding how hepatitis C and liver
damage develop and in testing possible treatments. The report of infection
of a mouse model with the hepatitis C virus is a significant and welcome ac
hievement.